| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/15/2009 | CN101406560A Stype for treating ankylosing spondylitis and preparation method thereof |
| 04/15/2009 | CN101406553A Medicament for treating chondropathy of cattle |
| 04/15/2009 | CN101406540A Plaster for treating rheumatism |
| 04/15/2009 | CN101406534A Chinese medicinal decoction for treating hyperosteogeny |
| 04/15/2009 | CN101406517A Use of pharmaceutical composition in preparing medicament for preventing and treating osteoporosis |
| 04/15/2009 | CN101406501A Medicine for treating rheumatic diseases |
| 04/15/2009 | CN101406497A Capparis spinosa extract as well as preparation method and application thereof |
| 04/15/2009 | CN101406466A Cinnamic acid transdermal patch and preparation technique thereof |
| 04/15/2009 | CN101406282A Blueberry leisure dairy food |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478016C Sarcandra solid dispersion and its preparing method |
| 04/15/2009 | CN100478007C Plaster for treating traumatic injuries and rheumatism, and its prepn. method |
| 04/15/2009 | CN100477994C Meloxicam containing skin topical paste formulation |
| 04/15/2009 | CN100477988C Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517907 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 04/14/2009 | US7517881 Triazine derivatives, their preparation and therapeutic application thereof |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517850 Calcium phosphate nanoclusters and their applications |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517529 Using gene-regulatory peptide |
| 04/14/2009 | CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/14/2009 | CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2355341C The use of ara as a supplement for a lactating woman |
| 04/14/2009 | CA2213261C Therapeutics of osteoarthritis and inflammatory joint disease |
| 04/14/2009 | CA2204493C Application of superoxide dismutase in liposomes |
| 04/14/2009 | CA2170479C Benzothiophene compounds, intermediates, compositions, and methods |
| 04/09/2009 | WO2009045753A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | WO2009045497A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044722A1 Gene susceptible to disease associated with intervertebral disc degeneration and use thereof |
| 04/09/2009 | WO2009043106A1 Inorganic selenium and angiogenesis |
| 04/09/2009 | WO2009043093A1 Hif inhibition |
| 04/09/2009 | WO2009003905A3 Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| 04/09/2009 | WO2008156645A3 Pharmaceutical compositions and uses |
| 04/09/2009 | WO2008148867A3 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 04/09/2009 | WO2008144754A3 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 04/09/2009 | WO2008142164A3 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 04/09/2009 | WO2008138943A3 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 04/09/2009 | WO2008107533A3 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093539 Anti-angiogenic compositions and methods of use thereof |
| 04/09/2009 | US20090093526 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 04/09/2009 | US20090093516 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | US20090093506 Copper antagonist compositions |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093475 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/09/2009 | US20090093444 Cathepsin Cysteine Protease Inhibitors |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093427 Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7 |
| 04/09/2009 | US20090093419 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/09/2009 | US20090093414 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) |
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090093393 Methods For Selective Targeting |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | CA2701778A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701355A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/08/2009 | EP2044957A1 Treatment agent for inflammatory bowel disease |
| 04/08/2009 | EP2043646A2 Glucocorticoid receptor modulator and methods of use |
| 04/08/2009 | EP1565475B1 Diazinopyrimidines and their use as protein kinase inhibitors |
| 04/08/2009 | EP1519749B1 Chemotactic factor inhibitor for inhibiting inflammatory reactions |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN201216754Y Health-care fragrant pillow of traditional Chinese medicine for neck |
| 04/08/2009 | CN101405001A Methods of inhibiting BTK and SYK protein kinases |
| 04/08/2009 | CN101401939A Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 04/08/2009 | CN101401934A T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/08/2009 | CN101401928A Pain easing catablasm for bone regeneration and preparation method thereof |
| 04/08/2009 | CN101401912A Chinese medicament preparation for treating porosis dysfunction type nonunion |
| 04/08/2009 | CN101401893A Pill for treating protrusion of lumbar vertebral disc |
| 04/08/2009 | CN101401892A Traditional Chinese medicine for curing gout |
| 04/08/2009 | CN101401888A Chinese medicament preparation for treating gout |
| 04/08/2009 | CN101401883A Traditional Chinese medicine decoction for treating gout |
| 04/08/2009 | CN101401869A Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny |
| 04/08/2009 | CN101401868A Keep-fit massage medicine package for thermotherapy |
| 04/08/2009 | CN101401865A Chinese medicine composition for curing gout |
| 04/08/2009 | CN101401846A Bi-syndrome treating Chinese medicine preparation |
| 04/08/2009 | CN101401834A Uses of boraginaceae cynoglossum plant and its extract in preparing medicament for treating diseases such as hyperosteogeny, arthritis |
| 04/08/2009 | CN101401833A Composition for preventing and/or treating osteoporosis |
| 04/08/2009 | CN101401804A Uses of salvianolic acid B in preparing medicament formulation for preventing and controlling osteoporosis |
| 04/08/2009 | CN100475849C Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475247C External application medicine for treating vertebrae lumbales hyperosteogeny |
| 04/08/2009 | CN100475246C 'Yizhihao'(artemisia)pain-relieving plaster for injury and rheumatism |
| 04/08/2009 | CN100475203C Preparing method of triptolide molecule microcapsule |
| 04/08/2009 | CN100475201C Preparing method of slow released diacetyl rheinic acid tablet |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |